This review on fingolimod for multiple sclerosis begins with a case vignette followed by a discussion of the clinical problem, the mechanism of benefit of this form of therapy, major clinical studies, the clinical use of this therapy, and potential adverse effects. The article ends with the authors' clinical recommendations on the management of the case in hand.